Showing posts with label based. Show all posts
Showing posts with label based. Show all posts

Wednesday, 5 April 2017

SOME RICE BASED FOOD FOR PEOPLE WITH CELIAC DISEASE CONTAIN RELEVANT AMOUNT OF ARSENIC


Rice is one of the few cereal grains consumed by people with celiac disease, as it does not contain gluten. However, it can have high concentrations of a toxic substance -- arsenic -- as revealed by the analyses of flour, cakes, bread, pasta and other foods made with rice, conducted by researchers from the Miguel Hernández University of Elche, Spain. The European Union is working to establish the maximum quantities of arsenic in these products.
Celiac disease affects almost 1% of the population of the western world, a group which cannot tolerate gluten and is thus obliged to consume products without it, such as rice. But this grain, depending on its origin, can also contain worrying levels of arsenic, a toxic and carcinogenic substance.
For the majority of consumers this does not pose any problem because they do not eat much rice every day, but this is not the case for celiac disease sufferers. Researchers from the Miguel Hernández University of Elche (UMH) have analysed the presence of arsenic in flour, bread, sweets, pastas, beers and milk made with rice and intended for this particular group of the population.
The results of the analyses, presented in the journal 'Food Additives & Contaminants', warn that some of these products contain "important contents" of total arsenic (As-t, up to 120 µg/kg) and inorganic arsenic (As-i, up to 85.8 µg/kg). Total arsenic is the sum of the organic arsenic, which is combined with carbon, and inorganic arsenic, which reacts with other elements such as oxygen, chlorine and sulphur, and is more harmful.
With these figures the As-t and As-i contents only of rice used as a main ingredient -- leaving aside the other components of the food products -- were estimated and were found to be as high as 235 and 198 µg/kg, respectively..
Moreover, the daily intake of inorganic arsenic by celiac disease sufferers -- a consequence of their consumption of rice products -- was calculated as between 0.45 and 0.46 µg/kg (micrograms per kilogram of body weight) for women and men weighing 58 and 75 kg respectively. And, in the case of children (up to the age of five), these figures are even higher, ranging between 0.61 and 0.78 µg/kg, according to another study published in the 'Journal of Food Science'.
A panel of experts from the European Food Safety Authority (EFSA) of the EU established in 2009 that there is evidence to suggest that an intake range of 0.3 -- 8.0 µg/kg of body weight per day entails a risk of developing lung, skin or bladder cancer. The estimated intakes in the two studies therefore vary within this range.
As Ángel Carbonell, co-author of the studies, explains: "These figures show that we cannot exclude a risk to the health of people who consume these kinds of products," although he recognises an important point: "The European Union has not yet established legal limits for the maximum content of arsenic in rice and rice-based foods, though it is currently working on this."
Lack of legislation
The researchers' recommendation is clear: "What is needed is for health agencies to legislate to limit the levels of arsenic that cannot be exceeded in rice-based foods intended for consumers who suffer from celiac disease." Until now, celiac disease was diagnosed predominantly in children, but in recent years the profile has changed and one in every five people with the disease is over 65 years old.
Currently, every EU country is taking samples of these products, analysing them and conveying the results to the EFSA to draw up a database broad enough to be able to make decisions. The Spanish Agency for Consumer Affairs, Food Safety and Nutrition (AECOSAN) has recently sent the Spanish report, put together in collaboration with the researchers responsible for this study..
Another important recommendation they make is to include quality information on labels: "The inorganic arsenic content in every food product should be indicated, and the variety of rice used and its provenance should be identified clearly, because some are more recommended than others," affirms Sandra Munera, one of the authors.
Arsenic is naturally present in Earth's crust, but in some regions its abundance is greater than in others, and its concentration also increases with the use of pesticides. The substance then spreads through water to rice, one of the few plants that is cultivated when flooded.
One of the 'cleanest' types of rice is from the Doñana National Park, as the use of pesticides has not been permitted here and arsenic is not naturally present in large quantities. On the other hand, in countries like India and Bangladesh, where waters are contaminated with inorganic arsenic and rice constitutes a staple food for the population, the result is currently one of the largest mass poisonings in history.


Saturday, 16 July 2016

Non smokers Can Benefit From Cannabis based Neuropathy Relief Too


Non-smokers and ex-smokers have often been put off trying cannabis for the relief of neuropathic pain (the laws of the land are often a discouraging factor too!) because of the potential damage to their lungs. However, using a vaporizer may well be the answer as it apparently delivers the same amount of THC, with the same biological effects, without the inhaling of tobacco, or other toxins normally associated with smoking. As always, assuming that you are able to access regular marijuana, the decision has to be made as to whether the benefits outweigh the risks. This article comes from imarijuana.com (see link below).
















Same Level Of THC and Fewer Toxins with Marijuana Vaporizer
Posted on 22 November, 2011 by admin

According to researchers from the University of California San Francisco, a smokeless cannabis-vaporizing device delivers the same level of active therapeutic chemical and produces the same biological effect as smoking cannabis.

Results of a UCSF study that focuses on delivery of the active ingredient delta-9-tertrahydrocannibinol, or THC, are reported in the online issue of the journal “Clinical Pharmacology and Therapeutics.”

“We showed in a recent paper in the journal ‘Neurology’ that smoked cannabis can alleviate the chronic pain caused by HIV-related neuropathy, but a concern was expressed that smoking cannabis was not safe. This study demonstrates an alternative method that gives patients the same effects and allows controlled dosing but without inhalation of the toxic products in smoke,” said study lead author Donald I. Abrams, MD, UCSF professor of clinical medicine.

The team of researchers looked at the effectiveness of a device that heats cannabis to a temperature between 180 and 200 degrees C, just short of combustion, which occurs at 230 degrees C. Eighteen individuals were enrolled as inpatients for six days under supervision in the General Clinical Research Center at San Francisco General Hospital Medical Center. The participants received three different strengths of cannabis on different days by two delivery methods–smoking or vaporization–three times a day, under the study protocol.

THC plasma concentrations were measured along with the exhaled levels of carbon monoxide, or CO, which served as a marker for the many other combustion-generated toxins inhaled when smoking.

“Using CO as an indicator, there was virtually no exposure to harmful combustion products using the vaporizing device. Since it replicates smoking’s efficiency at producing the desired THC effect using smaller amounts of the active ingredient as opposed to pill forms, this device has great potential for improving the therapeutic utility of THC,” said study co-author Neal L. Benowitz, MD, UCSF professor of medicine, psychiatry and biopharmaceutical sciences.

Benowitz added that pills tend to provide patients with more THC than they need for optimal therapeutic effect and increase side effects.

“By a significant majority, patients preferred vaporization to smoking, choosing the route of delivery with the fewest side effects and greatest efficiency,” said Benowitz.

Co-authors include Cheryl A. Jay, MD, UCSF neurology; and Starley B. Shade, MPH; Hector Vizoso, RN; and Mary Ellen Kelly, MPH, UCSF Positive Health Program at San Francisco General Hospital Medical Center.

The study was funded by the University of California’s Center for Medicinal Cannabis Research.
Reference:University of California – San Francisco

http://www.imarijuana.com/tag/smoked-cannabis